American symposium looks at new antineoplastic drug.
D000903:Antibiotics, Antineoplastic / Q000009:adverse effects / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use*; D015251:Epirubicin; D006331:Heart Diseases / Q000139:chemically induced; D006801:Humans; D013237:Stereoisomerism
D000903:Antibiotics, Antineoplastic; D015251:Epirubicin; D004317:Doxorubicin